Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Video: Assessing FDA Notice on Vinpocetine

In this video, <b>INSIDER</b> explores, in part, the industry's reaction to FDA's tentative determination that vinpocetine should not remain on the market as a dietary supplement.

Vinpocetine has been on the market as a dietary supplement for approximately the last 20 years. That could soon change thanks to a Federal Register notice that was published in September by FDA.

In this video, INSIDER explores:

-- FDA’s reasoning for its tentative conclusions that vinpocetine shouldn’t remain on the market as a dietary supplement;

-- reaction from trade associations to the Federal Register notice; and

-- a silver lining to the development for industry.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.